APA (7e ed.) Bronvermelding

Hester, J., Schiopu, A., Nadig, S., & Wood, K. (2012). Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

Chicago (17e ed.) Bronvermelding

Hester, J., A. Schiopu, SN Nadig, en K. Wood. Low-dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis in Vivo. 2012.

MLA (9e ed.) Bronvermelding

Hester, J., et al. Low-dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis in Vivo. 2012.